NEJM PERSPECTIVE: CONGRESS NEEDS TO HELP FDA COMBAT PROCEDURAL ABUSES

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Zachary Brennan Congressional action is necessary stop pharmaceutical companies from abusing the Orphan Drug Act, [...]